Sarepta Therapeutics and Genethon announce gene therapy research collaboration for Duchenne muscula

(AFM-T é l é thon) Sarepta Therapeutics, Inc. (NASDAQ:SRPT), and Genethon have signed a gene therapy research collaboration to jointly develop treatments for Duchenne muscular dystrophy (DMD).
Source: EurekAlert! - Biology - Category: Biology Source Type: news